Capital International Investors
VIR icon

Capital International Investors’s Vir Biotechnology VIR Stock Holding History

Capital International Investors’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-258,400
Closed -$2.62M – 464
2024
Q1 		$2.62M Hold
258,400
– – ﹤0.01% 415
2023
Q4 		$2.6M Hold
258,400
– – ﹤0.01% 422
2023
Q3 		$2.42M Hold
258,400
– – ﹤0.01% 423
2023
Q2 		$6.34M Hold
258,400
– – ﹤0.01% 413
2023
Q1 		$6.01M Hold
258,400
– – ﹤0.01% 413
2022
Q4 		$6.54M Hold
258,400
– – ﹤0.01% 402
2022
Q3 		$4.98M Sell
258,400
-2,402,282
-90% -$61.1M ﹤0.01% 408
2022
Q2 		$67.8M Sell
2,660,682
-1,668,834
-39% -$39M 0.02% 327
2022
Q1 		$111M Sell
4,329,516
-1,176,050
-21% -$34.9M 0.03% 299
2021
Q4 		$231M Sell
5,505,566
-3,218,090
-37% -$126M 0.05% 257
2021
Q3 		$380M Sell
8,723,656
-3,120,377
-26% -$135M 0.09% 201
2021
Q2 		$560M Buy
11,844,033
+21,270
+0.2% +$967K 0.13% 161
2021
Q1 		$606M Buy
11,822,763
+521,959
+5% +$28.1M 0.15% 144
2020
Q4 		$303M Buy
11,300,804
+17,710
+0.2% +$576K 0.08% 202
2020
Q3 		$387M Buy
11,283,094
+10,188,789
+931% +$439M 0.12% 164
2020
Q2 		$44.8M Hold
1,094,305
– – 0.01% 311
2020
Q1 		$37.5M Buy
1,094,305
+111,005
+11% +$2.98M 0.02% 285
2019
Q4 		$12.4M Buy
+983,300
New +$13.2M ﹤0.01% 345

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Capital International Investors's VIR Position: Q2 2024 in Review

Capital International Investors sold out of Vir Biotechnology (VIR) in Q2 2024, closing a stake of 258,400 shares — an estimated $2.62M sold.

Capital International Investors first reported a position in VIR in Q4 2019 and held it in 18 quarters. The position peaked at $606M in Q1 2021. 215 funds tracked by Wall St. Rank hold VIR as of Q2 2024.

  • Capital International Investors reported no remaining Vir Biotechnology position as of Q2 2024 after selling out during the quarter.
  • Capital International Investors sold 258,400 Vir Biotechnology shares in Q2 2024, an estimated $2.62M.
  • Capital International Investors first reported a position in Vir Biotechnology in Q4 2019 and held it in 18 quarters.
  • Capital International Investors's Vir Biotechnology position peaked at $606M in Q1 2021.
  • 215 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2024.

Based on Capital International Investors's 13F filing for Q2 2024, filed 13 Aug 2024.